Hikma Pharmaceuticals (HIK.LSE) Q3 2025 Earnings

Aug 7Confirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
75.82
83.76
91.7
99.63

Details

Expected EPS
83.63475
Actual EPS
90.69724
Surprise EPS
7.06
Surprise Percent
+8.44%

Description

⁨Hikma Pharmaceuticals⁩ (⁦HIK.LSE⁩) has reported earnings of ⁦90.69724⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts